Epidemiology and mechanism of antibiotic resistance in Helicobacter pylori

Gastroenterology

Volumn 115, Issue 5, 1998, Pages 1278-1282

  Megraud, F ^a  

^a HÔPITAL PELLEGRIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; MACROLIDE; NITROIMIDAZOLE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBOSOME RNA;

ANTIBIOTIC RESISTANCE; EPIDEMIOLOGY; HELICOBACTER PYLORI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

EID: 0031763796     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(98)70101-5     Document Type: Article

References (33)

1. F Mégraud Resistance of Helicobacter pylori to antibiotics Aliment Pharmacol Ther 11 suppl 1997 43 53
2. RJ Adameck M Wegener J Labenz M Freitag W Opferkuch GH Ruhl Medium-term results of an oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy Am J Gastroenterol 89 1994 39 42
3. A Occhialini M Urdaci F Doucet-Populaire CM Bébéar H Lamouliatte F Mégraud Macrolide resistance in Helicobacter pylori : rapid detection of point mutations and assays of macrolide binding to ribosomes Antimicrob Agents Chemother 41 1997 2724 2728
4. YJ Debets-Ossenkopp M Sparrius JG Kusters JJ Kolkman CMJE Vandenbroucke-Grauls Mechanism of clarithromycin resistance in clinical isolates of Helicobacter pylori FEMS Microbiol Lett 142 1996 37 42
5. K Hultén A Gibreel O Sköld L Engstrand Macrolide resistance in Helicobacter pylori : mechanism and stability in strains from clarithromycin-treated patients Antimicrob Agents Chemother 41 1997 2550 2553
6. J Versalovic D Shortridge K Kliber V Griffy J Beyer RK Flamm SK Tanaka DY Graham MF Go Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori Antimicrob Agents Chemother 40 1996 477 480
7. DE Taylor GE Zhongming D Purych T Lo K Hiratsuka Cloning and sequences analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations Antimicrob Agents Chemother 41 1997 2621 2628
8. NO Bukanov DE Berg Ordered cosmid librar y and high-resolution physical-genetic map of Helicobacter pylori strain NCTC11638 Mol Microbiol 11 1994 509 523
9. J-F Tomb G Sutton A Glodek L Zhou O White T Utterback R Fleischmann C Bult M Adams J Gocayne R Clayton N Akopyants DE Berg HO Smith C Fraser JC Venter The complete DNA sequence of the Helicobacter pylori genome Gut 39 suppl 2 1996 B59
10. J Versalovic MS Osato K Spakovsky MP Pina R Reddy GG Stone D Shortridge RK Flamm SK Tanaka DY Graham Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance J Antimicrob Chemother 40 1997 283 286
11. F Szczebara L Dhaenens P Vincent MO Husson Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori Eur J Clin Microbiol Infect Dis 16 1997 162 164
12. G Stone D Shortridge J Versalovic J Beyer RK Flamm DY Graham AT Ghoneim SK Tanaka A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistance Helicobacter pylori Antimicrob Agents Chemother 41 1997 712 714
13. M Pina A Occhialini L Monteiro HP Doermann F Mégraud Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase J Clin Microbiol 1998 (in press)
14. L Van Doorn YJ Debets-Ossenkopp A Marais K Van Hoek R Sanna F Mégraud JG Kusters WGV Quint Detection of 23S rRNA mutation associated to macrolide resistance of Helicobacter pylori by PCR and a reverse hybridization line probe assay (abstr) Gut 43 suppl 2 1998 A7
15. E Sevin D Lamarque JC Delchier CJ Soussy J Tankovic Identification de Helicobacter pylori et test de sensibilité à la clarithromycine par PCR réalisés directement sur biopsies gastriques (abstr) Lett Infect 13 suppl 1998 39
16. A Marais M Pina L Monteiro H Lamouliatte F Mégraud Direct detection of resistance of Helicobacter pylori to macrolides by PCR/DEIA in gastric biopsies (abstr) Gastroenterology 114 1998 A81
17. E Perez-Trallero M Montes M Alcorta P Zubillaga E Telleria Non endoscopic method to obtain Helicobacter pylori for culture Lancet 345 1995 622 623
18. SJO Veldhuyzen van Zanten J Goldie J Hollingsworth C Silletti H Richardson RH Hunt Secretion of intravenously administrated antibiotics in gastric juice: implications for management of Helicobacter pylori J Clin Pathol 45 1992 225 227
19. PA Shore BB Brodie CAM Hogben The gastric secretion of drugs: a pH partition hypothesis J Pharmacol Exp Ther 119 1957 361 369
20. MA Smith DI Edwards Redox potential oxygen concentration as factors in the susceptibility of Helicobacter pylori to nitroheterocycle drugs J Antimicrob Chemother 35 1995 751 764
21. A Goodwin D Kersulyte G Sisson SJO Veldhuyzen van Zanten DE Berg PS Hoffman Metronidazole resistance in Helicobacter pylori is due to null mutations in a gene ( rdxA) that encodes an oxygen-intensive NADPH nitroreductase Mol Microbiol 28 1998 383 393
22. G Cederbrant G Kahlmeter A Ljungh Proposed mechanism for metronidazole resistance in Helicobacter pylori J Antimicrob Chemother 29 1992 115 120
23. MP Dore DY Graham AR Sepulveda PBP-D a novel penicillinbinding protein is involved in amoxicillin resistance in Helicobac-ter pylori(abstr) Gastroenterology 114 1998 A109
24. RA Moore B Beckthold S Wong A Kureishi LE Bryan Nucleotide sequence of the gyrA gene and characterization of ciprofloxacinresistant mutants of Helicobacter pylori Antimicrob Agents Chemother 39 1995 107 111
25. A Weissfeld M Haber P Rose S Kids N Siejman Greographical distribution in the United States of primary resistance to clarithromycin and metronidazole in patients infected with Helicobacter pylori (abstr) Gastroenterology 112 1997 A328
26. ML Best DJM Haldane GS Bezanson SJO Veldhuyzen van Zanten Helicobacter pylori : primary susceptibility to clarithromycin in vitroin Nova Scotia Can J Gastroenterol 11 1997 298 300
27. AA van Zwet WA de Boer PM Scheeberger J Weel AR Jansz JC Thijs Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands Eur J Clin Microbiol Infect Dis 15 1996 861 864
28. N Broutet F Guillon E Sauty D Lethuaire F Mégraud Survey of the in vitro susceptibility of Helicobacter pylori to antibiotics in France. Preliminary results (abstr) Gastroenterology 114 1998 A81
29. H Wurzer L Rodrigo D Stamler A Archambault T Rokkas N Skandalis R Fedorak F Bazzoli E Hentschel P Mora A Archimandritis F Mégraud Short-course therapy with amoxicillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group Aliment Pharmacol Ther 11 1997 943 952
30. H Seppälä T Klaukka J Vuopio-Varkila A Muotiala DH Helenius K Lager P Huovinen The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland N Engl J Med 337 1997 441 446
31. E de Koster A Cozzoli C Vandenborre C Jonas P Denis J Otero M Deltenre Helicobacter pylori resistance to macrolides increases, to imidazoles remains stable (abstr) Gastroenterology 112 1997 A99
32. The report of the Digestive Health Initiative international Update Conference on Helicobacter pylori Gastroenterology 113 suppl 1997 S4 S8
33. Current European concepts in the management of Helicobacter pylori infection The Maastricht Consensus Report Gut 41 1997 8 13